Initial pathology in aggressive pituitary tumours and carcinomas: 2b or not 2b?-that is the question.

Trouillas, Jacqueline; Burman, Pia; Losa, Marco; McCormack, Ann; Petersenn, Stephan; Popovic, Vera; Theodoropoulou, Marily; Dekkers, Olaf M; Raverot, Gerald

Trouillas, Jacqueline; Burman, Pia; Losa, Marco; McCormack, Ann; Petersenn, Stephan; Popovic, Vera; Theodoropoulou, Marily; Dekkers, Olaf M; Raverot, Gerald.

Affiliation

Trouillas J; Faculty of medicine Lyon-Est, University Claude Bernard Lyon 1, Lyon 69372, France.
Burman P; Department of Endocrinology, Skåne University Hospital, Malmö, Lund University, Malmö 214 28, Sweden.
Losa M; Department of Neurosurgery, IRCCS San Raffaele, Vita-Salute University, Milan 20132, Italy.
McCormack A; Department of Endocrinology, St. Vincent's Hospital, Sydney 2010, Australia.
Petersenn S; ENDOC Center for Endocrine Tumors, Erik-Blumenfeld-Platz 27a, Hamburg 22587, Germany.
Popovic V; School of Medicine, University of Belgrade, Belgrade 11000, Serbia.
Theodoropoulou M; Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Munich 2333, Germany.
Dekkers OM; Department of Clinical Epidemiology, Leids Universitair Medisch Centrum Centrum voor Humane en Klinische Genetica, Leiden 2300 RC, Netherlands.
Raverot G; Faculty of medicine Lyon-Est, University Claude Bernard Lyon 1, Lyon 69372, France.

Eur J Endocrinol ; 188(4): C5-C8, 2023 04 05.

Article in En | MEDLINE | ID: mdl-36952293

Subject(s)

Carcinoma; Pituitary Neoplasms; Humans; Pituitary Neoplasms/pathology; Dacarbazine; Temozolomide

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pituitary Neoplasms / Carcinoma Limits: Humans Language: En Journal: Eur J Endocrinol Journal subject: ENDOCRINOLOGIA Year: 2023 Document type: Article Affiliation country: France Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google